Metal–organic frameworks (MOFs) as apt luminescent probes for the detection of biochemical analytes

Dongwen Luo ab, Jiefeng Huang b, Yanhong Jian b, Ayushi Singh d, Abhinav Kumar *d, Jianqiang Liu *bde, Ying Pan *ab and Qin Ouyang *c
aThe First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523808, China. E-mail: panying@gdmu.edu.cn
bGuangdong Provincial Key Laboratory of Research and Development of Natural Drugs, and School of Pharmacy, Guangdong Medical University, Guangdong Medical University Key Laboratory of Research and Development of New Medical Materials, Dongguan, 523808, China. E-mail: jianqiangliu2010@126.com
cDepartment of General Surgery, Dalang Hospital, Dongguan, Guangdong, China. E-mail: ouyangqin8@sina.com
dDepartment of Chemistry, Faculty of Science, University of Lucknow, Lucknow-226007, India. E-mail: abhinavmarshal@gmail.com
eAffiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

Received 9th March 2023 , Accepted 11th June 2023

First published on 30th June 2023


Abstract

The detection of active substances in the body is very important for good human health as it gives important insights into the smooth functioning of the body. Most of the conventional materials that can be used as suitable probes require complicated fabrication methodologies, have poor stability and are susceptible to environmental effects. In contrast, metal–organic frameworks (MOFs) offer unique advantages as probes for testing analytes due to their tunable porosity, good specific surface area and ease of modification. Unlike previously reported perspectives/reviews, this perspective focuses on the latest applications of MOFs as detection materials for hydrogen peroxide, various metal ions, hydrogen sulfide, organic small molecules, glutathione, and organic macromolecules such as nucleic acids, and focuses on providing a more detailed mechanism of action. Also, the basic principles of action utilized by this class of materials are discussed.


1. Introduction

There are many physiologically active substances in human cells, viz. hydrogen peroxide, hydrogen sulfide, various classes of organic molecules and ions and others. These biologically active substances play a very important role in the normal physiological functioning of cells. They are responsible for a wide range of functions such as bio-catalysis, regulation and information transfer in various metabolisms and contribute to various cellular processes such as differentiation, growth, migration, proliferation and phagocytosis. These phenomena play a vital role in the maintenance of the body's optimal state and hence, detection of these cellular components is essential to understand the biochemical phenomenon appropriately. Also, the accurate detection of these active substances develops a deep understanding of the current state of cellular health, health screening and the diagnosis as well as the treatment of diseases. However, testing of these active substances requires the use of specialized materials.

Over the past few decades, investigators have developed a range of materials for the detection of these active substances that are broadly categorized as natural enzyme-based detection materials, enzyme-like bioactive detection materials and non-enzyme detection materials. Natural enzyme-based detection materials have some inherent disadvantages, including their inherent instability, vulnerability to external influences, susceptibility to deactivation, and stringent experimental requirements.1 Enzyme-like detection materials include conducting polymers, metals and their compounds, mesoporous carbon and graphene composites, among others.2 These materials are highly sensitive and are currently used in the detection of various analytes; while non-enzymatic detection materials include noble metals,3 transition metals,4 metal oxides,5 or sulfides,6 and carbon-based materials.7 Due to their simplicity, low price, and comparatively high stability, these materials are frequently extensively used. Furthermore, the ability of these materials to combine with certain organic nanoparticles is another crucial quality. Nanomaterials' distinctive physicochemical characteristics, such as their high biocompatibility and outstanding electrical conductivity, enable them to significantly improve the performance of traditional detection materials.

A new class of porous materials known as metal–organic frameworks (MOFs) is made up of coordination bonds that bind metal centers or clusters to organic building blocks.8,9 MOFs offer benefits such as adjustable porosity, high specific surface area, and customizable architectures when compared to typical porous materials such as porous carbon, porous catalysts and porous polymers.10–14 All these properties could (at least theoretically) address the need to develop novel sensing materials with high sensitivity, excellent selectivity, fast response times, enhanced stability and reusability.15 Hence, MOF materials have promising future in the fields of bioimaging, adsorption,16,17 catalysis,18 magnetism,19 sensing,20,21 and drug delivery.22 Recently, the biological uses of MOFs have drawn a lot of attention in recent years, particularly in the area of electrochemical biosensing.15,23,24 MOFs possess open metal sites at their backbone that provide mimetic catalytic properties and amplify electrochemical signals that effectively improve the sensitivity of detection.25 Recently, researchers have employed MOFs as biosensors for the detection of different components in cells such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), glutathione (GSH),26 metal ions,27–29 and cancer biomarkers (hydrogen sulfide (H2S), hydrogen peroxide (H2O2), and ascorbic acid).30–32 Also, as compared to conventional detection techniques, MOF-based biosensors have better sensing efficiency, enabling detection at fg mL−1 or even lower concentrations.33,34

The basic principle of MOF-based materials for sensing of analytes is shown in Fig. 1. The mechanism of action mainly involves the following steps: first, the material catalyzes the reduction of the analytes to produce an electrochemical signal; second, the structure of the material is altered upon interaction with the analyte, thus producing a fluorescent effect; third, certain materials have a fluorescent effect of their own and undergo a fluorescence enhancement on interaction with the analytes. Since different analytes have to be detected, the materials used for the detection these analytes are also different. The timeline for the development of MOFs for the detection of glutathione, hydrogen peroxide, hydrogen sulfide and ionophores is presented in Fig. 2.


image file: d3tb00505d-f1.tif
Fig. 1 The basic principles utilized for sensing of biochemical analytes by MOF-based materials.

image file: d3tb00505d-f2.tif
Fig. 2 Timeline for the development of tests for MOFs in five areas.

In view of the importance of MOFs as apt sensing systems to selectively and efficiently detect a plethora of biological analytes, this perspective focuses on the recent investigations on the use of MOFs as biosensors for the detection of hydrogen peroxide (H2O2), metal ions, hydrogen sulfide and organic molecules in biological cells. The main MOF-based materials as sensors for the analytes mentioned in this paper are classified and presented in Table 1.

Table 1 MOF-based materials as sensors for different biochemical analytes
MOF Substances tested Synthetic method Detection limits Detection range Ref.
Fe-Hemin-MOFs H2O2 Ultrasound synthesis method 0.57 μM 1–61 μM, 61–1311 μM 2
Au-NPs/Cu-HHTP-NSs H2O2 Solvothermal method 0.0056 μM 50 nM–16.4 mM 46
pFeMOF/OMC H2O2 Hydrothermal method 0.45 μM 0.5–70.5 μM, 70.5–1830.5 μM 47
AuNFs/Fe3O4@ZIF-8-MoS2 H2O2 Electrochemical deposition method 0.9 μM 5 μM–120 mM 48
ZIF-67-Au@Pt H2O2 Ultrasound synthesis method 0.086 μM 0.8 μM–3 mM 49
SGO@HKUST-1 H2O2 Solvothermal method 0.49 μM 1 μM–5.6 mM 50
PtCu@MOF/C H2O2 Self-sacrificing templates 0.22 μM 1 μM–3 mM 51
Cu-Hemin MOFs/3D-RGO H2O2 Co-precipitation method 0.14 μM 10–24400 μM 52
MIL-47(V)-OH H2O2 Electrochemical methods 4.38 μM 4.38–43.98 μM, 50.33 μM–2.24 mM 53
Zr-UiO-66-B(OH)2 H2O2 Solvothermal method 0.015 μM 60
UCNP@ZIF-NiSx H2O2 In situ growth method 0.032 μM 0.05–20 μM 61
TbTATB Zn2+ Solvothermal method 0.0105 μM 64
AuNCs/Zn-MOF Zn2+ Hydrothermal method 0.006 μM 12.3 nM–24.6 mM 65
DNAzyme-MOFs Zn2+ DNA solid phase synthesis, solvothermal method 0.0035 μM 66
ZIF-8@Cmim Fe2+ Solvothermal method 7.64 μM 71
Fe-MIL-88NH2@RhB Cu2+ Solvothermal method 4.23 μM 73
UiO-66@N3 H2S Solvothermal method 118 μM 80
CD-MONT-2 H2S Solvothermal method 0.058 μM 81
Al-MIL-53-N3 H2S Solvothermal method 0.090 μM 82
CuxOS-@ZIF-8 H2S In situ growth method 0.0022 μM 83
Mi-UiO-67 GSH Solvothermal method 0.010 μM 95
MnO2 NS@Ru(bpy)32+-UiO-66 GSH In situ growth method 0.28 μM 96
TPNP-1 GSH Solvothermal method 0.087 μM 0–80 μM 97
PANMOF miRNA In situ growth method ∼0.001 μM 0–1000 nM 102
CoNi-MOF miRNA Solvothermal method 0.0014 μM 1–10 nM 104
TP-CHA-UiO-66 miRNA Solvothermal method 160 μM 1–60 nM 105


2. Application of MOFs in the detection of H2O2

2.1. Electrochemical detection method

As one of the body's metabolites and a key mediator in physiological processes, hydrogen peroxide (H2O2), a reactive oxygen species (ROS) produced by the respiratory chain and cellular metabolism, plays a critical role in cell proliferation, cell differentiation, cell death, intracellular signaling, mediating immune responses and chronic disease responses. It majorly contributes towards the oxidative stress in the organism.35,36 Excess H2O2 can cause cytotoxicity and cellular damage by attacking methionine residues and cysteines. On the other hand, its high content can also lead to some pathological defects, such as cancer,37,38 diabetes,39,40 Alzheimer's disease,41,42 nucleic acid damage,43 and so on. Since H2O2 is closely linked to signal transduction and cellular activity, sensitive monitoring and effective regulation of intracellular H2O2 levels is therefore essential in health screening, disease diagnosis and therapy. The ordered structural framework of MOFs can lead to specific reactions that can be repeatedly used for the detection of specific analytes due to their stability.34 However, accurate and sensitive detection of intracellular H2O2 is not an easy task due to the complex and variable nature of the cellular environment. Although scientists have developed several analytical strategies, including photo-electrochemical, fluorescence and spectrophotometric methods, to detect H2O2, these methods have limitations due to the requirements of expensive fluorescent agents, complex operational procedures and low sensitivity. In contrast to these approaches, electrochemical biosensors have gained attention because of their high sensitivity, quick analysis, and real-time on-line continuous monitoring in complex systems.44 Because of their great sensitivity and specificity, natural enzymes were commonly utilized in the early days of electrochemical H2O2 sensors.45 However, their utilities as sensors were constrained by the enzyme's inherent disadvantages. MOFs ameliorate the inherent shortcomings of these enzymes when paired with them due to their unique qualities (e.g., structural porosity and functional variety).

A new heme metal–organic framework (Fe-hemin-MOFs) with distinct peroxidase-like bioactivity was reported by Zhao et al. This material exhibited excellent hydrogen peroxide catalytic activity and can be further loaded with chitosan-reduced graphene oxide (CS-rGO), which resulted in an enhanced electrochemical signal. The mechanism of action is as follows: H2O2 is first reduced to H2O via the material catalytic center hemin (Fe2+), which is oxidized to hemin (Fe3+). Hemin (Fe3+) is then reduced at the electrode and generates an electrical signal. In this process, CS-rGO accelerates the transfer of electrons and further promotes the catalytic process of H2O2. The ligand structure of the haemoglobin-MOFs can shield the haemoglobin active centre and increases stability, and haemoglobin can imitate artificial enzymes with strong electrocatalytic activity. The synergistic effect of CS-rGO and Fe-hemin-MOFs could have an enhanced electrochemical signal and provided an excellent H2O2 reduction capability in the sensor. This material had a lower detection limit than most electrochemical sensors based on peroxidase-like MOFs. This is encouraging for the detection of H2O2 at low concentrations. It also allowed real-time monitoring of H2O2 release from living cells, thereby providing a promising strategy for biomolecular monitoring.2

In 2022, Huang and co-workers developed a high-performance electrochemical biosensor based on a highly active dual-nanosome amplification system, comprised of ultrathin two-dimensional (2D) conductive metal–organic framework (C-MOF) nanosheets (NSs) that was modified with high-density ultra-fine gold nanoparticles (Au-NPs), Au-NPs/Cu-HHTP-NSs, and explored its application in the C-MOF-NSs (i.e. Cu-HHTP (HHTP = 2,3,6,7,10,11-hexahydroxybenzophenanthrene)-NSs). These materials provided a large surface area and abundant active open metal sites that greatly enhanced the catalytic activity towards H2O2. The large number of exposed oxygen atoms was used as anchor sites to deposit high density ultrafine Au-NPs without agglomeration (Fig. 3). The material was synthesized using a solvothermal method. The anionic surfactant sodium dodecyl sulphate (SDS) acted as a barrier, reducing interlayer build-up and weakening interlayer interactions, which in-turn resulted in the formation of ultra-thin large size nanosheets during sonication, thereby providing a high specific surface area with abundant anchoring sites. The nanoenzyme Au-NP materials were grown in situ on the reduced precursor tetrachloroauric acid (HAuCl4) without adding reducing or capping agents. Notably, due to the synergistic effect of the highly active Cu-HHTP-NSs and Au-NPs and their unique structural and electrical properties, the prepared nano-hybrid modified electrodes exhibited good sensing performance for H2O2 with extremely low detection limits and high sensitivity.46


image file: d3tb00505d-f3.tif
Fig. 3 Synthesis of Cu-HHTP-NSs and real-time tracking of mitochondrial release of H2O2.46 Reproduced with permission. Copyright 2022, Elsevier.

Also, some enzyme-like materials in combination with MOFs can engender detection materials that display good sensing and detection activity with high accuracy. pFeMOF/OMC, a new porphyrin-iron metal–organic framework (pFeMOF) modified with ordered mesoporous carbon (OMC), was synthesized by Liu et al. in 2017. The mechanism of action of this sensor operated through the reduction of H2O2, generating an electrical signal for detection purposes. Fe3+ can strongly coordinate with the carboxylate of the porphyrin moiety to produce an amplified electrochemical signal due to the peroxidase-mimicking properties of pFeMOF. The carbon skeleton of OMC exhibited a limiting effect on the growth of pFeMOF crystals, reducing the aggregation of pFeMOF and thus producing more active sites for H2O2 reduction. Also, an increase in the number of mesopores accelerated the diffusion rate. Additionally, the introduction of OMC improved the conductivity and stability. More importantly, the biosensor possesses the potential to detect the release of H2O2 from living cells and can accurately detect H2O2 even at low concentrations.47 Lu et al. also developed an electrochemical biosensor Fe3O4@ZIF-8 hybrid nanosensor. This nanosensor was prepared by electrodepositing gold nano-flowers (AuNFs/Fe3O4@ZIF-8-MoS2) on a magnetic metal–organic framework (MMOF) supported over molybdenum disulphide (MoS2) nanosheets in which the magnetic Fe3O4 nanoparticles have high simulated peroxidase activity, while the MOF backbone ZIF-8 possesses a large pore size and high specific surface area. The mechanism of action of the sensor is as follows: the H2O2 released by the cell is specifically captured by it, and the H2O2 is reduced by redox reaction and generates an electron transfer effect, thereby producing a characteristic electrical signal. However, it was found that the MMOF Fe3O4@ZIF-8 nanomaterials readily dissolved into the electrolyte solution and subsequently generated irreducible electrochemical reactions. Long-term stability, electrical conductivity, and catalytic characteristics of the materials may all be significantly enhanced by MoS2 nanosheets and one-step electrodeposited gold nanostructures. MoS2 nanosheets and electrodeposited gold thin films have a considerable impact on the surface state retention of Fe3O4@ZIF-8 nanomaterials, as well as their electrocatalytic activity. With a low detection limit of 0.9 μM and an ultra-wide linear range of 5 μM–120 mM, the material demonstrated substantial electrocatalytic reduction activity towards hydrogen peroxide. The sensor has been successfully utilized to track the release of extracellular H2O2 from H9C2 cardiomyocytes.

As shown in Fig. 4, H9C2 cardiomyocytes were used as a model for H2O2 release from live cells by adding ascorbic acid (AA) as the stimulant and the ability of the sensor to detect H2O2 was assessed by detecting superoxide production by dehydrogenation staining (DHE). As shown in Fig. 4A and B, AA-treated H9C2 cells exhibited much higher levels of reactive oxygen species than untreated H9C2 cells. As presented in Fig. 4C, the addition of 400 μM of AA to a PBS solution containing H9C2 cardiomyocytes (2 × 106 cells) resulted in a change in the electrochemical signal of approximately 0.12 μM. There was no significant difference in the current signal with merely AA or cells, demonstrating that H2O2 was released by H9C2 cells. Fig. 4D shows the electrochemical experiments after seeding on cells in culture dishes for phase comparison. Most of the cells were alive and typically attached to the culture dish. However, the sensor posed new challenges in terms of sensitivity and selectivity when it comes to detecting extracellular H2O2 in the culture dish. Hence, combining microfluidic chips and electrochemical sensors may give new possibilities for cell attachment and growth in the future, allowing for sensitive and selective observation of cell activity.48


image file: d3tb00505d-f4.tif
Fig. 4 DHE fluorescence staining of H9C2 cells. (A) Without AA and (B) with 400 μM AA for 5 min. (C) Current effects of AuNFs/Fe3O4@ZIF-8-MoS2/GCE on H9C2 cells spiked with 400 μM AA (with and without H9C2 cells) and H9C2 cells without AA (cell number 2 × 106 cells). (D) Microscopic image of H9C2 cells cultured on a cell culture dish after electrochemical detection (scale bar is 200 μm).48 Reproduced with permission. Copyright 2020, Elsevier.

Wang et al. reported a novel nanosensor for enzymes, ZIF-67-Au@Pt. The nanoparticle ZIF-67 possessed a hollow structure with Au@Pt nano-flowers loaded on its surface. Using the porous nature and large surface area of the MOF material, more particles can be adsorbed for catalysis. The Au@Pt nanoflower structure has a core–shell bimetallic structure. On the surface of the bimetallic catalyst, the Au particles are positively charged, while the addition of a negatively charged second active metal (e.g. Pt) increases the negatively charged area of the entire catalyst surface, which facilitated the H2O2 catalytic reaction. The sensor had a good linear range of 0.8 μM–3 mM with a correlation coefficient of 0.9936 and a detection limit of 86 nM. The main advantage of this material was that it not only had good electrical conductivity to amplify the current signal, but the core–shell nanoflower formed by Au@Pt can effectively catalyze the oxidation of H2O2. This sensor offers a promising application in biomedical monitoring.49

In non-enzymatic materials, precise detection of H2O2 can be achieved even in the absence of enzyme recognition and catalysis due to the material's inherent activity towards H2O2. Wang et al. used graphene oxide (GO), benzene 1,3,5-tricarboxylic acid (BTC) and copper nitrate (Cu(NO3)2) to synthesize a novel metal–organic backbone (MOF) containing an electroactive nanocomposite with graphene fragments and HKUST-1 to create SGO@HKUST-1. They showed that GO acted as an effective structural guide to induce the transformation of HKUST-1 from an octahedral structure to a hierarchical flower-like structure. The special feature of this process is that the graphene oxide is broken down into small fragments involved in the formation of HKUST-1, which are then converted to their reduced form during the reaction, thereby significantly increasing the surface area, electronic conductivity and redox capacity of the material. In addition, the synergistic interaction of graphene and HKUST-1 provided enhanced electrocatalytic activity, fast responsiveness and high selectivity for H2O2 reduction. Compared to other sensors, this sensor showed excellent performance in terms of linear range and detection limits for measuring H2O2. The reasons for this may be as follows: first, the presence of abundant and appropriately sized pores of MOFs in the material facilitates the transport of H2O2 molecules through the interface; second, the SGO attached to the MOFs has excellent electronic conductivity and high catalytic capacity for the electro-reduction of H2O2. This material exhibited satisfactory results as a sensing material for the electrochemical detection of H2O2 in complex biological samples (e.g. human serum).50 Chen et al. synthesized a unique non-enzymatic electrochemical sensor, PtCu@MOF/C, in which Pt-Cu alloy nanoparticles acted like a H2O2 active center that were pre-loaded on a conductive support and wrapped by a copper-based MOF shell using a self-sacrificing template route that formed a semi-enveloped structure. This semi-enclosed structure offered a lower limit of material detection than the fully enclosed structure of the composite. The synergistic effect operating at the interface between the MOF shell and PtCu conductive support provided better selectivity for the detection of H2O2 compared to the unmodified sensor. The novel MOF armored structure of the as-prepared PtCu@MOF/C sensor, especially PtCu@HKUST-1/C with smaller MOF pores, exhibited excellent interference immunity, high stability and high reproducibility in the detection of H2O2 (even when released from living cells).51 Zhou et al. in the year 2021 reported a copper-hemin metal–organic framework nano-flower/3D-reduced graphene oxide (Cu-hemin MOFs/3D-RGO) based on copper-hemin MOFs. This nanocomposite material was synthesized by co-precipitation using hemin as a ligand and then modified with 3D-RGO. This nanocomposite exhibited a three-dimensional hollow spherical flower-like structure with large specific surface area and mesoporous properties. This opened up the new possibility of loading more biomolecules and greatly improved the stability by protecting hemoglobin. In addition, the introduction of 3D-RGO effectively enhanced the electrical conductivity of Cu-hemin MOFs, thereby exhibiting good electrochemical properties towards H2O2 and enabled in situ real-time detection of H2O2 release from living cells.52 Yang et al. designed a sensitive sensor, MIL-47(V)-OH, in the presence of negatively charged superoxide ions, that selectively and sensitively detected H2O2. Interestingly, by adjusting the ligand in particular by replacing 2-amino terephthalic acid with the 2,5-dihydroxy terephthalic acid of MIL-47(V), the reaction was accelerated at least by a factor of 10 times. In addition, the low detection limit and wide linear range of the MIL-47(V)-OH biosensor enabled it to be used for in situ monitoring of H2O2 release from tumour cells. Also, the conversion of H2O2 into superoxide negative ions without applying voltage demonstrated the inhibitory effect of MIL-47 on tumour cells, enabling highly selective and rapid in situ detection of H2O2 release from living cells.53

Of the abovementioned materials, different MOFs showed high sensitivity and accurate detection of hydrogen peroxide in vivo due to their unique structural characteristics as electrochemical sensors. The enzyme-like MOFs offered good electrocatalytic effects on hydrogen peroxide artificial enzymes, and the addition of MOFs allowed them to overcome the inherent drawbacks of enzymes, which uplifted their performance. The enzyme-like MOFs can mimic hydrogen peroxide properties and generate amplified electrochemical signals; while for the non-enzymatic MOFs, the synergistic interaction between the components is also active against hydrogen peroxide and they possess high electrical conductivity. In conclusion, these MOF-based materials are important for the detection of hydrogen peroxide in vivo. Fig. 5 illustrates the syntheses and application of several representative materials.


image file: d3tb00505d-f5.tif
Fig. 5 (A) Schematic diagram of the synthesis of ferrohemoglobin MOFs/CS rGO for real-time monitoring of H2O2 released from living cells.2 Reproduced with permission. Copyright 2020, Analytica Chimica Acta. (B) Schematic diagram of an AuNFs/Fe3O4@ZIF-8-MoS2 nanocomposite modified glassy carbon electrode (GCE) for electrochemical determination of H2O2 released from living cells under drug stimulation.48 Reproduced with permission. Copyright 2020, Sensors and Actuators B: Chemical. (C) Demonstration of MIL-47(V)-OH (left) detection of H2O2 released from tumour cells and rapid detection of H2O2 by modulating the ligand of MIL-47 (right).53 Reproduced with permission. Copyright 2022, Elsevier.

2.2. Fluorescence detection method

Among many methods for the detection of hydrogen peroxide in vivo, the use of fluorescence spectroscopy employing small molecules has received significant attention. Fluorescence and in vivo bioluminescence methods have now been shown to be highly sensitive and selective in the detection of H2O2 in living cells. Moreover, these techniques do not cause harm to the body, hence offering the possibility of real-time detection of H2O2in vivo.

Currently, some luminescent MOFs show great potential for the detection of H2O2 that includes, the ZIF series,54 the Ln-based MOFs,8,55 the PCN series,56,57 and the UiO series.58,59 However, due to the lack of in-depth knowledge and design of the materials, the advantageous features of MOFs are not fully explored, which directly led to a more common detection capability. Mostakim and co-workers synthesized a new boronic acid-functionalized Zr-MOF, Zr-UiO-66-B(OH)2 in 2018 by reacting ZrOCl2·8H2O and 2-borobenzene-1,4-dicarboxylic acid (BDC-B(OH)2) in the presence of formic acid in N,N-dimethylacetamide (DMA) by solvothermal reaction. It is worth noting that in the presence of H2O2, the boronic acid functionalized ligand (BDC-B(OH)2) of this material underwent selective reaction with it and the additional –B(OH)2 group was converted to the –OH group. This formed Zr-UiO-66-OH, which exhibited strong fluorescence and does not undergo conversion to other ROS. This reflected the specificity of the fluorescence effect of the material on H2O2 and its selective detection of H2O2 even in the presence of other interfering ROS. This probe was highly sensitive with a detection limit of 0.015 μM, which was lower than the detection limit of other MOF-based H2O2 fluorescent sensors and hence can be effectively used to detect H2O2 in living cells.60

Additionally, the background auto-fluorescence effect of complex biological matrices can hinder the detection of H2O2 in living organisms. In 2019, Hao et al. synthesized a hybrid component, the assembly of which consists of an upconverted nanoparticle (UCNP) core and chiral NiSx NPs (written UCNP@ZIF-NiSx) wrapped in a zeolite imidazole frame-8 (ZIF-8) shell. Fig. 6 shows a TEM image of the process and the structure of the component used to detect H2O2in vivo. The experiments showed that the UCNP@ZIF-NiSx nanocomponent exhibited strong circular dichroism (CD) signals at 440 and 530 nm. However, in the presence of H2O2, the CD signal intensity of this component decreased and the color disappeared, which was probably due to the degradation of NiSx NPs by H2O2. When the concentration of H2O2 was between 0.05 and 20 μM, the electronic absorption spectra of this probe overlap with the green emission of UCNPs appearing at 540 nm, and the reaction of H2O2 with the probe led to the reduction of the absorption of the probe at 660 nm, the disappearance of the CD signal and the recovery of the luminescence signal. Even in the presence of other interfering components, there was no significant change in the CD or luminescence signal. This indicated that the probe offered good selectivity and high sensitivity. This strategy showcased the potential of chiral nanocomponents for ROS detection and provided a new idea for the development of chiral nanomaterials for biomedical and biological analysis.61


image file: d3tb00505d-f6.tif
Fig. 6 (A) Schematic diagram of the UCNP@MOF-NiSx nanocomponent used to detect intracellular H2O2. (B) (a) a TEM image of the UCNP@ZIF nanostructure; (b) a TEM image of the UCNP@MOF-NiSx nanocomponent and the inset shows a high-resolution TEM image of NiSx in the nanocomponent.61 Reproduced with permission. Copyright 2019, Journal of the American Chemical Society.

In summary, the fluorescence and in vivo luminescence properties using these materials have been shown to be highly sensitive and selective for the detection of H2O2 in living cells. However, there are some urgent issues that need to be addressed. First, there are sporadic reports on the fluorescent MOF-based materials that find utility as sensors for H2O2. Second, the fluorescence intensity of these materials is still not strong enough and needs to be further improved.

3. Application of MOFs in ion detection

Life activity is an intricate series of biological reactions involving cellular metabolism, nutrient acquisition, signal transduction and other physiological processes. It is the collective result of the involvement of many biologically active substances in various chemical reactions, of which ions are very important. These ions are involved in the formation of various enzymes or some protein carriers in the body, operation of the electron transport system, synthesis of some hormones and vitamins, the interaction with biological macromolecules such as nucleic acids, etc. Therefore, high as well as low concentrations of ions in the body can lead to disruption of normal physiological functions and cause various diseases. This makes the detection of ions particularly important. Different methods have been used to detect different ions, such as high performance liquid chromatography (HPLC), chemi-luminescence, anodic dissolution voltammetry (IASV), X-ray absorption spectrometry (XRD), ICP-atomic emission spectrometry (ICP-AES), ICP-mass spectrometry (ICP-MS), atomic absorption spectrophotometry (AAS), etc. However, their complexity, stringent requirements, high costs and high skill requirements severely limit their large-scale application. New and effective methods are therefore required that are capable of identifying and detecting heavy metal ions in samples. Also, these techniques must be simple to operate, rapid in response, sensitive and selective.29 Hence, various nanomaterials such as gold nanoparticles, metal oxides, carbon-based nanomaterials, and polymer nanoparticles have been selectively used in this field in recent years. MOFs have received much attention due to their regular size and well-defined channel cavities.62 Today, MOF-based materials have been developed as novel sensing materials for biomolecules and their design and synthesis has become a hot topic of research. The materials designed for the detection of different ions are not identical. In view of this, in the next section, the detection of some ions in biological systems has been covered and discussed.

3.1. MOFs for the detection of Zn2+

Zn2+ plays a key role in many fundamental biological processes, including gene expression, neurotransmission, cell regulation and many more. Due to its unique electronic configuration, it is present in biological systems in the +2 oxidation state. Abnormal levels of Zn2+ may lead to chronic inflammation, dysplasia, Alzheimer's disease, etc. In addition, Zn2+ is an important indicator of the nutrient content of food.63 Therefore, the development of a sensitive and selective probe for the detection of Zn2+ is of great importance. In recent years, the development in luminescence technology has opened up new avenues for the detection of this ion. By monitoring the changes in the luminescence signal, it is possible to obtain a more stable luminescence signal over time and characterized by high sensitivity, convenience and rapid response. In general, luminescent molecular systems capable of sensing Zn2+ cations consist of two basic parts, the Zn2+ binding group and the luminescent centre that can display emission. In 2018, Fan et al. designed a luminescent terbium metal–organic backbone TbTATB as the luminescent sensor for Zn2+. They used a tripartite planar organic ligand 4,4′,4′′-triazido-2,4,6-trialkyl-tribenzoic acid (H3TATB) as a ligand to construct luminescent MOFs with terbium that displayed unique luminescent properties of terbium due to the preferential coordination to oxygen atoms. In addition, Zn2+ possesses a strong coordination tendency to coordinate with nitrogen atoms and the triazine-containing ligand provides the functionalized site for Zn2+ detection. As expected, almost all Tb3+ ions were coordinated to oxygen atoms, leaving a large number of exposed Lewis basic sites. Experiments have revealed that the material has a stronger selectivity for Zn2+ than other competing metal ions, as well as a strong luminescence intensity and higher sensitivity. The detection limit for this sensor is 10.5 nM, which is even lower than the minimum standard level of Zn2+ in serum. Therefore, its ability to detect Zn2+ is very powerful. In addition, the material was biocompatible and capable of imaging Zn2+ targets in the coexistence of living cells. This sensitive and highly selective sensor therefore had the potential to be a powerful indicator of Zn2+ in biological systems.64 In the same year Li et al. reported AuNCs/Zn-MOF nanocomposites, which can be used as fluorescent probes for the detection of Zn2+. These Au nanoclusters (AuNCs) detected Zn2+ by aggregation-induced emission enhancement (AIEE) in aqueous media and by in situ formation of Zn-MOF-constrained AuNCs. This was in contrast to organic solvent-induced AuNCs aggregation and organic solvent-induced AuNCs. Instead, AuNCs were prepared by reducing tetrachloroauric acid (HAuCl4) with glutathione (GSH) as a reducing and protective agent. Fluorescence experiments showed that the fluorescence quantum yield of the AuNCs/Zn-MOF composites was increased to about nine times when a certain amount of Zn2+ was added to the mixture of AuNCs and 2-methylimidazole (2-MIM), compared to that of single AuNCs. The material offered an extremely low detection limit of 6 nM, which provided a firm basis for its use in the determination of Zn2+ in human serum and hence provided an unconventional application of gold nanocluster/MOF composites in metal ion detection.65

Shi et al., developed a nano-probe for two-photon imaging of DNAzyme-MOFs based on phosphate ion activation. As shown in Fig. 7, the strong coordination between the phosphate O and the Zr center in the MOF induced Zn2+-specific RNA cleavage DNAzyme onto the MOF. This synergistic effect inhibited the extracellular activity of DNAzyme; however, upon cell entry, DNAzyme was released from the MOF by competitive binding of phosphate ions present at high intracellular concentrations. Upon release, the two-photon (TP) fluorophore-labelled DNAzyme substrate strand was cleaved in the presence of Zn2+, releasing a shorter strand of DNA labelled with a TP fluorophore, thereby resulting in a strong fluorescent signal. The addition of TPF fluorophores to the nanoprobe facilitated near infrared excitation, which allowed highly sensitive and specific imaging of Zn2+ in live cells and tissues at greater depths than previously possible. The TP imaging capabilities facilitated the monitoring of apoptosis-related Zn2+ elevations in live cells and deep tissues. This phosphate ion activation strategy offers great potential for a variety of medical applications.66


image file: d3tb00505d-f7.tif
Fig. 7 The construction of the TP-DNAzyme-MOFs nanoprobe and its application in the detection of intracellular Zn2+ content.66 Reproduced with permission. Copyright 2020, ACS.

3.2. MOFs for the detection of Fe2+

Iron is one of the most abundant transition metal ions in humans and other animals. Under human physiological conditions, it is usually found in two forms, namely ferrous (Fe2+) and ferric (Fe3+) ions. Iron is involved in a variety of physiological processes such as oxygen transport,67 storage metabolism,68 electron transfer69 and cellular respiration.70 Both iron deficiency and its excess can have a very significant impact on the body. Iron deficiency can cause anaemia in humans, while excess iron can damage liver and kidney function, causing hepatitis and haemochromatosis. There are numerous sensors for iron, but most of them are small molecule sensors and the tendency of Fe2+ to oxidize under aqueous aerobic conditions impedes the detection of iron. The combination of MOFs with these sensors could improve this situation. For example, Yogesh et al. in 2021 developed curcumin immobilized zeolite imidazolium salt skeleton-8 (ZIF-8@Cmim) as a probe for the detection of Fe2+. Curcumin has many functional groups, mainly in two mutually variable isomeric forms, namely diketones and ketoalcohols. The presence of α,β-unsaturated β-diketone groups in curcumin act as chelating agents to undergo complexation with metal ions, thus improving the water stability of curcumin in neutral and basic media. As shown in Fig. 8, when ZIF-8@Cmim, with an intrinsic fluorescent effect, binds to Fe2+, Fe2+ binds to Cmim to form Cmim- Fe2+ complex and the original fluorescent effect was observed to be disrupted and the change in colour of the solution was visible to the naked eye for detection. Curcumin itself has a low solubility in aqueous media, but when loaded onto ZIF-8 its solubility increases significantly. This material has a low detection limit of 7.64 μM, which allows it to detect Fe2+ at the cellular level. This material was highly selective for Fe2+ and provided a new idea for the design of the material.71
image file: d3tb00505d-f8.tif
Fig. 8 The mechanism of action of ZIF-8@Cmim.71 Reproduced with permission. Copyright 2021, Elsevier.

3.3. MOFs for the detection of Cu2+

In our body, the concentration of Cu2+ ensures the appropriate functioning of organs and metabolic processes. It is an essential nutrient element in the physiological cycle. In addition, Cu2+ is a specific trace ion with beneficial and cytotoxic effects in various enzymatic processes and it also act as cofactors for many essential biological processes. However, the detection of Cu2+ is currently not an easy task, requiring either high-end instruments or complicated sample preparation methods. Recently, some new MOF-based materials have been developed and applied in practical assays.72 Zhang et al. reported a dual-emission fluorescent probe Fe-MIL-88NH2@RhB/Cu2+ based on Fe-MIL-88NH2@RhB for separate detection of Cu2+/Glu and continuous detection of Glu in a highly selective and sensitive ratiometric fluorescent (RF) mode. This versatile RF probe encapsulated RhB in a Fe-MIL-88NH2 porous structure, selectively recognizes Cu2+/Glu based on a unique coordination principle and has good linearity with off/on fluorescence behaviour. Furthermore, Fe-MIL-88NH2@RhB/Cu2+ when continuously treated with Glu, the quenching in fluorescence of the platform (after the perception of blue emission by Cu2+) was further restored. The two characteristic emission peaks corresponding to Fe-MIL-88NH2 and RhB appeared at 433 nm and 580 nm, respectively thereby confirming the successful preparation of the nanocomposite (Fig. 9A). Whereas, the emission intensity of this probe at 433 nm dynamically decreased after the addition of Cu2+, while, the fluorescence signal of the RhB molecule remained unaltered and can therefore be designated as an internal fluorescence reference. Fig. 9B shows a linear correlation between the bursting effect of Fe-MIL-88NH2@RhB and the Cu2+ concentration. In addition, Fig. 9C estimates the selectivity of the Fe-MIL-88NH2@RhB sensing system after the addition of Cu2+ and other analytes (Na+, K+, Mg2+, Ca2+, Zn2+, Co2+, Ba2+, Sr2+, Cd2+, Mn2+). It can be noted that after the addition of the other ions for more than 20 min, the change in fluorescence signal was very small and only Cu2+ produced a significant quenching in the fluorescence intensity. This suggested that the probe still has a good fluorescence response to Cu2+ even in the presence of these interfering species. Upon further addition of Cu2+, its blue fluorescence at 433 nm decreased rapidly, indicating that the probe was unaffected by the other co-existing ions (Fig. 9D). The use of the Fe-MIL-88NH2@RhB probe had successfully enabled the imaging of split channels of Cu2+ and Glu in living A549 cells with low cytotoxicity and efficient sensing of Glu in serum by molecular logic gates. This can be used for the development of medical carrier tools for the initial diagnosis of amyotrophic lateral sclerosis. Also, it has a bimodal (colour and luminescence) response for Cu2+ and good selectivity for this metal cation in the presence of other interfering analytes. It can be fabricated into a portable, low reading on-line test strip for the detection of Cu2+ with significant visual colour development.73
image file: d3tb00505d-f9.tif
Fig. 9 (A) Luminescence spectra of Fe-MIL-88NH2@RhB at different Cu2+ concentrations in aqueous solution. (B) Standard curve of Cu2+ concentration. (C) Fluorescence intensity response of Fe-MIL-88NH2@RhB to other metal ions. (D) Interference test of Fe-MIL-88NH2@RhB against other metal ions.73 Reproduced with permission. Copyright 2021, Elsevier.

The majority of the probes discussed in the preceding sections had deep tissue penetration, good selectivity, and outstanding biosafety. All of these features make these probes extremely useful for bioassays and biological studies. But there are, however, some issues with these probes. The majority of the techniques employed for these probes are fluorescence-based, with only a few exceptions using alternative approaches. It is envisaged that additional detection technologies will arise in the future, providing even better options for the detection of these ions.

4. Application of MOFs in the detection of hydrogen sulfide

Hydrogen sulfide (H2S) has been shown to be involved in a variety of physiological processes, such as immune response, angiogenesis, antioxidant, neurotransmission, and apoptosis. In recent years, studies have found that abnormal levels of hydrogen sulfide (H2S) are also associated with a variety of diseases, such as diabetes, Alzheimer's disease, cirrhosis, Down's syndrome and cancer.74 Therefore, the presence of abnormal concentrations of hydrogen sulfide (H2S) in the human body is an important signal, and H2S is a potential target for the identification and treatment of these diseases. The examination of H2S in biological systems is of great significance for understanding its role in related physiological and pathological processes. The construction of an efficient H2S detection platform has also become a new focus of research. Over the past decade, varieties of fluorescent probes have been used for the rapid detection of H2S. According to current studies, the sensing mechanism of H2S detection of fluorescent probes can be divided into three categories: H2S reduction reaction, H2S nucleophilic reaction and metal sulfide precipitation reaction.75–77 Due to the many excellent properties of MOF materials, in recent years, scientists have studied the application of MOF materials in the construction of efficient hydrogen sulfide (H2S) detection platform. Fluorescence can be produced by using organic ligands with a tendency to absorb UV/visible light.78 Fluorescence is the most commonly used strategy for the effective detection of H2S in liquid or biological samples.79 Nagarkar et al. firstly synthesized UiO-66@NH2 using a solvothermal method, and then chemically modified the free –NH2 into –N2 by diazotizing –NH2. Thus, the metal–organic azide framework (MOF) UiO-66@N3 was obtained as a selectively opened fluorescent probe for H2S detection.80 To detect the fluorescence switching response of UiO-66@N3 to H2S, they excited UiO-66@N3 at 334 nm and recorded the fluorescence spectra in the range of 350–650 nm. The results showed that the fluorescence reaction of the material was very weak because the electrons withdraw from the azide group and remain shut down. However, the fluorescence intensity of UiO-66@N3 treated with Na2S was significantly enhanced. The quantitative response of the probe UiO-66@N3 towards H2S was measured by fluorescence titration in HEPES buffer (10 mM and pH 7.4). The incremental addition of Na2S resulted in the enhancement of the characteristic fluorescence emission peak at 436 nm. Also, the plot constructed between fluorescence intensity at 436 nm versus H2S concentration showed a linear correlation. A detection limit of 118 mM for H2S was obtained for UiO-66@N3, which was within the range of H2S concentrations in most biological systems.

In order to evaluate the response time of UiO-66@N3 towards H2S, the periodic fluorescence spectra were obtained (Fig. 10A). The results showed enhancement in fluorescence intensity by 16 times with t1/2 = 13.6 s, and the reaction was completed within tR = 180 s. This rapid response illustrated the potential of UiO-66@N3 for real-time intracellular H2S imaging. To demonstrate the sensing capabilities of UiO-66@N3 in biological systems, they performed cytotoxicity and live cell imaging studies using HeLa cell lines. The cytotoxicity of UiO-66@N3 was determined by 3-(4,5)-dimethylthiahiazo(-z-y1)-2,5-di-phenytetrazoliumromide (MTT) assay and the toxicity level of UiO-66@N3 to HeLa cells was determined by different concentrations of UiO-66@N3. They first incubated HeLa cells with UiO-66@N3 for 6 hours after which HeLa cells still exhibited low toxicity (Fig. 10B). In cell imaging studies, very low intensity fluorescence was observed when HeLa cells were incubated with UiO-66@N3 for 6 hours (Fig. 10C–E). However, strong fluorescence was observed in HeLa cells after incubation with Na2S for 30 min under the same conditions (Fig. 10F–H). These results indicated that UiO-66@N3 has a high selectivity and fast fluorescence initiation reaction against H2S and thus, can be used to monitor H2S in cells. The main mechanism behind the fluorescence turn-on response of UiO-66@N3 towards H2S was attributed to the reduction of a “dark” azido group to an emitting amino group. This was the first example of MOF showing a rapid and highly selective fluorescence initiation response to H2S under physiological conditions.


image file: d3tb00505d-f10.tif
Fig. 10 (A) Fluorescence response of 1-N3 towards the addition of Na2S after 0, 60, 180, 300, 420 and 540 seconds. Inset: Time dependence of emission intensity at 436 nm. (B) HeLa cells were treated with 1-N3 before adding MTT for 6 h. Results are expressed as % of the control (100%). (C–E) Fluorescence imaging of HeLa cells incubated with 1-N3. (F–H) Fluorescence imaging of HeLa cells incubated with Na2S.80 Reproduced with permission. Copyright 2014, Springer Nature.

Xin et al. developed a cyclodextrin (CD)-based metal–organic nanotube (CD-MONT-2′) as a fluorescence turn-on probe for the detection of H2S in living cells.81 To investigate the fluorescence response of CD-MONT-2 to H2S, they dissolved CD-MONT-2′ in DMSO to prepare 10 μM stock solutions, and then recorded the emission spectra at 350–650 nm under 330 nm excitation. The results showed that CD-MONT-2′ exhibited weak fluorescence in DMSO. When 1 mL H2S was added to the stock solution, the fluorescence intensity was significantly enhanced (Fig. 11A). Furthermore, to explore the fluorescence opening response of CD-MONT-2′ to sulfide, they added different concentrations of Na2S (0–10 μM) into the solution and recorded the fluorescence spectra (Fig. 11B). In order to explore the fluorescence selectivity of CD-MONT-2′, Na2SO4, Na2S2O3, Na2SO3 and glucose, thiol amino acids and non-thiol amino acids were selected as the control group of Na2S. The fluorescence intensity images of the obtained results are shown in Fig. 11C and D. These results indicated that CD-MONT-2′ has a high selectivity and moderate sensitivity fluorescence opening reaction against H2S molecules. The sensing mechanism is based on the coordination between H2S and the metal ion in the center of the probe to adjust the fluorescence intensity. Fig. 11E reveals the mechanism of CD-MONT-2′ opening of fluorescent probes. During the subsequent cellular imaging experiments, they added PBS solution with different concentrations of Na2S into the treated HeLa cells and analyzed the fluorescence imaging results of each group. The results showed that the CD-MONT-2′ probe not only detected the external sulfides added to the cell culture, but also sulfides produced by cells in the body. This also suggested that CD-MONT-2′ has the potential for real-time intracellular H2S imaging with a highly selective and moderately sensitive fluorescence-on response to H2S molecules in the cell growth environment.


image file: d3tb00505d-f11.tif
Fig. 11 (A) Schematic diagram of fluorescence intensity changing with time within 15 min of adding H2S. (B) The fluorescence spectra of different concentrations of Na2S (0–10 μM) were added into the culture medium. (C and D) Fluorescence intensity images of CD-MONT-2′ in different substance systems. (II0)/I0 (where I0 is the initial fluorescence intensity, and I is the fluorescence intensity after the addition of the analyte). (E) Schematic diagram of the mechanism of CD-MONT-2′ opening fluorescence probe.81 Reproduced with permission. Copyright 2016, Springer Nature.

Das et al. prepared Al-MiL-53-N3 using a solvothermal method and investigated its ability to detect intracellular H2S in a live cell imaging assay.82 They first implanted a probe (25 μM) into macrophages and then treated the cells with a Na2S solution (5 μM), which induced intracellular H2S production. The results showed that cells loaded with probes and treated with Na2S showed bright fluorescence, which suggested that the Al-MIL-53-N3 probe had the ability to recognize H2S in cells. Yuan et al. reported a novel two-mode probe based on a circular dichroic spectrum (CD) and fluorescence signal (CuxOS@ZIF-8).83 CD is an ideal and powerful bioassay technique because it is highly sensitive and does not damage cells during the detection process. Fig. 12 shows the principle of the CuxOS@ZIF-8 nanosensor for endogenous H2S detection. The use of ZIF-8 conferred high levels of selectivity toward H2S. Only H2S was allowed to react with the internal skeleton of CuxOS. To investigate the stability and biocompatibility of the CuxOS@ZIF-8 probe, they tested the probe in an environment with a pH of 5.0–7.4. In the Phosphate Buffered Saline (PBS) buffer (pH = 7.4), the hydrodynamic size of the nano-probe remained unchanged which indicated the good stability of the probe. In a biocompatibility study of CuxOS@ZIF-8, it was observed that there were few adverse effects in living cells for 48 h even at concentrations of CuxOS@ZIF-8 as high as 100 μg mL−1, and CuxOS@ZIF-8 did not cause ROS reactions in HeLa cells. These results showed that the CD and fluorescence signal system created by CuxOS@ZIF-8 has good stability and biocompatibility, and has high selectivity and sensitivity for H2S detection. The probe employed both CD and fluorescence signals to accurately detect H2S not only in vitro, but also in living cells and in vivo. In the detection process, the chiral CuxOS was transformed into the achiral CuxS, thus realizing the ultra-sensitive detection. This strategy opened up new avenues for the development of chiral nanostructures for biocatalysis, bioimaging, and diagnostics in life sciences.


image file: d3tb00505d-f12.tif
Fig. 12 CuxOS@ZIF-8. Schematic diagram of detecting H2S in cells using a nanosensor.83 Reproduced with permission. Copyright 2020, Wiley.

To sum up, most of the current studies on the detection of H2S by MOFs are in the stage of in vitro experiments, which are conducted by simulating the cell environment in vitro, and until now in vivo experiments in animals have rarely been executed. Also, most experiments are executed by adding exotic sulfides (Na2S, H2S). Apart from this, in order to activate the fluorescence effect of fluorescent probes, some potential sulfide sources such as GSH and L-cysteine (L-Cys) should be increased to investigate the fluorescence effect of open probes.

5. Application of MOFs in the detection of organic molecules

5.1. Application of MOFs in detecting GSH

Glutathione (GSH) is a tripeptide containing γ-amide bond and sulfhydryl group, composed of glutamic acid, cysteine and glycine. It is present in almost every cell of the human body. GSH is an important endogenous antioxidant,84 which has antioxidant and detoxification effects.85 Normal GSH levels in cells help in removing free radicals and maintain normal immune system function. The abnormal level of GSH is closely related to the occurrence and development of many serious diseases. For example, studies on the mechanisms of drug resistance have shown that the resistance is mediated by multiple factors, in which high levels of glutathione may play an important role. GSH may produce drug resistance by resisting oxidative stress, repairing DNA damage caused by chemotherapy,86 or combining with chemotherapeutic drugs to promote the efflux of chemotherapy drugs.87 Therefore, accurate imaging and sensing of glutathione in vivo is of great significance for understanding its related physiological or pathological activities, which is conducive for disease prevention or the development of new therapeutic techniques. At present, the main methods for detecting GSH in organisms are high performance liquid chromatography,88 electrochemistry,89 colorimetry,90 photoelectric chemical method,91 surface-enhanced Raman spectroscopy,92 enzyme-linked immunosorbent,93 and fluorescent assays.94 Compared to other detection methods, fluorescence detection possesses non-destructive characteristics, real-time monitoring, rapid response, high selectivity and sensitivity, etc. Therefore, GSH detection and cell imaging have good application prospects. In recent years, scientists are attempting to use MOFs as a fluorescent platform for the detection of GSH.

Li et al. constructed a nanoscale metal–organic framework (Mi-UiO-66 and Mi-UiO-67) fluorescent probe for detecting Cys and GSH using a solvothermal method.95 They uplifted the fluorescence sensing capability of the materials by introducing maleimide groups into the NMOFs, that resulted in Mi-UiO-66 and Mi-UiO-67 displaying excellent photophysical properties for biological applications. This is because incorporating organic fluorescent switches into periodic and porous NMOFs using this strategy not only effectively prevented the aggregation-induced bursts (ACQ), but also effectively prevented dye leaching. Transmission electron microscopy (TEM) showed that the size of Mi-UiO-66 and Mi-UiO-67 nanoparticles was ≤100 nm with even size distribution, which was suitable for living cell imaging. They also examined the stability of the obtained Mi-UiO-66 and Mi-UiO-67 in cell culture, and the PXRD measurements indicated that they were very stable and suitable for use in biological imaging. To explore the selectivity of Mi-UiO-66 and Mi-UiO-67 for Cys and GSH, they applied Mi-UiO-66 and Mi-UiO-67 in the presence of various interferons (Ala, Val, Leu, Ile, Pro, Phe). The fluorescent response in this environment showed that only Cys and GSH could induce significant fluorescence enhancement, indicating that Mi-UiO-66 and Mi-UiO-67 were fluorescence probes with good selectivity.

Zhu et al. prepared MnO2 NS@Ru(bpy)32+-UiO-66 nanocomposites coated with manganese dioxide nanosheets by an in-situ growth method as a fluorescence sensing platform for GSH in living cells.96 They investigated the selectivity, stability and biocompatibility of MnO2 NS@Ru(bpy)32+-UiO-66 nanocomposites. First, the selectivity of this platform was evaluated by investigating the fluorescence response toward various potentially competing interferences (KCl, MgSO4, FeCl2, Glu, Tyr, BSA, UA, Lys, AA, Cys). The results showed that the fluorescence intensity of glutathione was significantly greater than that of other substances. These results indicated that MnO2 NS@Ru(bpy)32+-UiO-66 nanocomposites have high selectivity for GSH. In addition, the fluorescence detection of 20 μM GSH was performed for eight consecutive times with no perceptible change in the results, indicating that the fluorescence detection system has good stability. Using HeLa cells as an example, this group analyzed the biocompatibility of MnO2 NS@Ru(bpy)32+-UiO-66 by MTT assay. When HeLa cells were exposed to MnO2 NS@Ru(bpy)32+-UiO-66 at a concentration lower than 120 μg mL−1 for 24 h, no significant decrease in cell survival was observed. These results indicate that MnO2 NS@Ru(bpy)32+-UiO-66 has good biocompatibility and has significant application prospects in GSH detection in vivo.

Yang et al. for the first time developed a new sensitive two-photon NMOF fluorescent probe (TPNP-1) based on the host-guest interaction.97 As shown in Fig. 13, TPNP-1 can be used to monitor fluctuations in endogenous GSH levels in living cells. They first synthesized UiO-66-NH2 by solvothermal reaction. Secondly, due to the unique porous structure of UiO-66-NH2, which possess excellent surface negative potential and has excellent adsorption ability on cationic dyes, they opted to introduce DMASM dye to UiO-66-NH2, which provided the two-photon fluorescence system DMASM⊂UiO-66-NH2. Finally the KMnO4 solution of different concentrations (50, 100, 150, 200, 250 μg mL−1) was introduced into the DMASM⊂UiO-66-NH2 in aqueous medium with strong stirring at room temperature that yielded TPNP-1.


image file: d3tb00505d-f13.tif
Fig. 13 Schematic diagram of TPNP-1 detecting intracellular GSH.97 Reproduced with permission. Copyright 2021, Elsevier.

In the cell experiment, considering the difference in GSH content between cancer cells and normal cells, HepG2, HeLa and normal hepatocyte L02 cells were selected for the GSH in situ fluorescence imaging experiment (Fig. 14A–I).


image file: d3tb00505d-f14.tif
Fig. 14 (A) SEM image of TPNP-1 (scale bar = 100 nm). (B) TEM image of TPNP-1 (scale bar = 100 nm). (C) DLS data of TPNP-1. (D) DLS data of DMASM⊂UiO-66-NH2. (E) XPS plot of TPNP-1. (F) Zeta potential diagram for UiO-66-NH2, DMASM⊂UiO-66-NH2 and TPNP-1. (G–I) SEM-mapping image of TPNP-1.97 Reproduced with permission. Copyright 2021, Elsevier.

After incubating different cell lines and probe TPNP-1 for 4 hours in DMEM medium of 37 °C, they excited the two photon confocal images at 880 nm using a nanosecond laser (Fig. 15A and B). Thereafter, TPNP-1 was applied to tissue imaging of mouse liver sections. The liver sections were first incubated with PBS solution containing TPNP-1 for 30 min, and then the fluorescence intensity changes at different scanning depths were recorded using a two-photon microscope under Z-scan mode. Imaging showed (Fig. 15C) that two-photon fluorescence imaging of rat liver sections showed a penetration depth of 170 nm with a detection limit of 87 nM. The results showed that the two-photon imaging based on the probe can be realized not only in living cells, but also in deep living tissues. The construction of the TPNP-1 two-photon fluorescence probe effectively solved the problem of poor penetration of a single photon fluorescence probe into biological tissue.


image file: d3tb00505d-f15.tif
Fig. 15 (A) Fluorescence images of HeLa cells: (a) 50 μg mL−1 TPNP-1 after 500 μM NEM incubated; (b) 50 μg mL−1 TPNP-1; (c) 50 μg mL−1 TPNP-1 after 200 μM LPA incubated; (B) relative fluorescence intensities of a, b and c; (C) two photon fluorescence images of fresh mice liver tissue slice.97 Reproduced with permission. Copyright 2021, Elsevier.

5.2. Application of MOFs in nucleic acid detection

MicroRNA (miRNA) is a class of endogenous small RNAs with 20–24 nucleotides in length. It plays a variety of important regulatory roles in cells and is involved in a series of important processes during life, including early development, cell proliferation, apoptosis, cell death, lipid metabolism and cell differentiation. In addition, miRNAs are considered to be biomarkers closely related to cell carcinogenesis,98 and an emerging diagnostic and prognostic biomarker. Therefore, it is of great significance to develop a reliable sensing strategy to monitor miRNA in living cells. Conventional miRNA detection methods include northern blotting,99 real-time quantitative PCR,100 and microarrays.101 However, none of these methods could monitor the miRNA level expressed in living cells in real time, and they also have different shortcomings. Therefore, it is of great significance to develop some new methods that are more sensitive and selective for the detection of miRNA in cells. In recent years, many scientific groups have employed MOFs for the construction of an miRNA detection platform to improve the stability, biocompatibility, sensitivity and other advantages of the detection platform.

Traditional miRNA assays are unable to monitor miRNA levels in living cells in real time. Wu et al. constructed a novel fluorescent biosensor (PANMOF) based on a fluorophore-labeled peptide nucleic acid (PNA) probe combined with an NMOF (UiO-66) vector for monitoring multiplexed miRNAs in live cancer cells (Fig. 16).102 This miRNA sensor not only enabled quantitative and highly specific detection of multiple miRNAs in living cancer cells, but also allowed precise and in situ monitoring of spatial and temporal changes in miRNA expression. When the PNA probe was firmly bound to the nanoporous NMOF carrier, the fluorescence of dye-labelled PNAs was dramatically burst.103 However, in the presence of targeted miRNAs, the dye-labelled PNAs were released from the NMOF and hybridized with the target miRNAs, resulting in a recovery of fluorescence of the PNA probe. They first validated the effectiveness of the proposed miRNA sensing scheme using the PANMOF platform in homogeneous solution. Preliminary experiments showed that PANMOF can be used as a bio-sensing platform for miRNAs. Thereafter, they applied the PANMOF system to two human breast cancer cells, MCF-7 and MDA-MB-231, for miRNA detection studies. The cultured cells were first incubated with the FAM-PNA21-NMOF complex (a PANMOF complex) for 14 hours.


image file: d3tb00505d-f16.tif
Fig. 16 Schematic diagram of the PANMOF sensing mechanism.102 Reproduced with permission. Copyright 2015, RSC.

Earlier studies have shown that NMOF nanoparticles can be internalized into biological cells through phagocytosis that resulted in bright fluorescence of the FAM-PNA21-NMOF complex (Fig. 17) showing the fluorescence intensity exhibited by different cell lines after incubation. In addition, they explored the potential cytotoxicity of PANMOF by MTT assay. The results showed that two cancer cells retained more than 90% of their activity after treatment with PANMOF at concentrations of up to 80 μg mL−1, which indicated its excellent biocompatibility. In summary, the PANMOF bio-sensing platform possesses excellent sensitivity, specificity and biocompatibility, providing an important method for monitoring the dynamic changes of miRNA expression in living cancer cells.


image file: d3tb00505d-f17.tif
Fig. 17 Fluorescence images obtained after 14 h incubation with FAM-PNA21-NMOF and FAM-scPNA-NMOF.102 Reproduced with permission. Copyright 2015, RSC.

Hu et al. reported a bimetallic organic backbone (CoNi-MOF) using a solvothermal method,104 as an efficient sensing platform for miRNA-126 detection. Compared to the homo-structured monometallic Co-MOF or Ni-MOF, the bimetallic CoNi-MOF exhibited superior electrochemical activity due to the synergistic interaction between multiple metal centres and electrochemically active ligands. They tested CoNi-MOF for selectivity as well as stability and in the presence of multiple interferers (MM1, MM2, miRNA-141, miRNA-155 and miRNA-21) and it displayed high selectivity for miRNA-126, which could be attributed to the efficient and specific hybridization. Also, the measurement using the miRNA-126/cDNA/CoNi-MOF(1[thin space (1/6-em)]:[thin space (1/6-em)]1)/AE based electrode was executed continuously for 15 days and the results showed that the electrochemical impedance spectroscopy (ESI) response did not change significantly throughout the experiment, thereby demonstrating the good stability of miRNA-126/cDNA/CoNi-MOF. Notably, they also tested the miRNA-126/cDNA/CoNi-MOF for reusability, where they probed the reusability of the biosensor CoNi-MOF by measuring miRNA-126 (10 pm) detection at five separate electrodes. The data showed a low RSD of 1.01% for the EIS response, and after refreshing again, the EIS returned to the original level, which demonstrated the reusable nature of the biosensor CoNi-MOF.

Yang et al. reported a novel two-photon nanoprobe TP-CHA-UiO-66,105 using MOF as a nanocarrier and hairpins as a two-photon fluorescent signal amplifier for miRNA imaging of tumour cells and deep tissues. Where TP was a fluorophore, and its excellent imaging performance could facilitate and boost imaging of tumour-associated miRNAs in live tumour cells and tissues. Catalytic hairpin assembly (CHA),106 was an ultra-sensitive and highly efficient selective RNA amplification detection strategy that identified the target and amplifies the signal. Fig. 18A illustrates the imaging process of TP-CHA-UiO-66 in live cancer cells. Upon penetration into the cell, intracellular phosphate coordinated with the Zr atoms of the MOF, thereby leading to the release of hairpins on the surface of TP-CHA-MOFs. The intracellular miRNA triggered the formation of H1-H2 duplex structures, leading to the switching mode of the TP fluorescent signal and enabling the amplification and detection of the target miRNA. After the preparation and characterization of TP-CHA-MOFs, investigators performed in vitro fluorescence imaging experiments as well as intracellular fluorescence imaging experiments on TP-CHA-MOFs. In an in vitro fluorometric assay, they dispersed TP-CHA-MOF nanoprobes (10 μL, 1 μM DNA) in a phosphate-buffered solution (PBS, 10 mM, pH = 7.4) similar to the cellular environment for 6 h at 37 °C, then added miRNA-21 (0–120 nM) at different concentration gradients to this mixture and incubated for 1.5 h at 37 °C. Fluorescence spectra were recorded at 400 nm excitation wavelength and the same experiments were then performed under the same conditions in HEPES and Tris buffers. As shown in Fig. 18B, only weak fluorescent emission was observed in HEPES and Tris buffers containing miRNA-21, whereas intense fluorescent emission resulted in PBS buffer due to phosphate triggering the release of H1 and H2 from MOFs. These results demonstrated the good selectivity of the TP-CHA-MOFs fluorescent probe for the PBS buffer solution, which indirectly indicated that the TP-CHA-MOFs fluorescent probe can be applied within the cellular environment due to the presence of phosphate in the PBS buffer similar to the intracellular environment. Subsequently, they examined the in vitro fluorescence sensing performance of TP-CHA-MOFs nano-probes by recording the fluorescence spectra at different concentrations of TP-CHA-MOFs nanoprobes (Fig. 18C). The fluorescence intensity gradually increased as the miRNA-21 concentration increased from 0 to 120 nM. In intracellular imaging experiments, they used the CCK-8 method to investigate the cytotoxicity of TP-CHA-MOFs nanoprobes on living cells. HEK293, HeLa and MCF-7 cells were incubated with different concentrations of TP-CHA-MOFs. At the end of the incubation, the cellular activity was still over 88% which demonstrates the good biocompatibility of the TP-CHA-MOFs nanoprobes. Compared to conventional single-photon fluorescent probes, the two-photon fluorescent probe TP-CHA-UiO-66 offered better penetration and enabled fluorescence imaging in deeper biological tissues. The TP-CHA-UiO-66 nanoprobe enabled efficient TP fluorescence imaging of deep miRNA-21 in tumour tissues at penetration depths of 20–160 μm.


image file: d3tb00505d-f18.tif
Fig. 18 (A) Schematic diagram of the imaging process of TP-CHA-UiO-66 in living cells. (B) F/F0 for TP-CHA-MOFs incubated with miRNA in DPBS, HEPES, or Tris–HCl buffer. (C) Fluorescence spectra of various concentrations of miRNA (0–120 nM).105 Reproduced with permission. Copyright 2022, Elsevier.

Compared with previously reported fluorescent probes for miRNA detection, the two-photon nanoprobe TP-CHA-UiO-66 reported by Yang et al. exhibited better selectivity, biocompatibility and penetration, which significantly improved the efficiency of miRNA detection and has promising applications in medical diagnostics.

In summary, investigation on the construction of miRNA biosensing platforms for detection is still at a preliminary stage. Most of the studies have been conducted only with in vitro fluorescence experiments and cellular experiments, while in vivo experiments on animals are relatively rare. The limits of detection of miRNAs with the fluorescent probes constructed so far are relatively low, and the stability of the probes needs to be improved.

6. Conclusions

This perspective reviewed the recent developments in the use of MOF materials as probes and biosensing platforms for diverse chemicals (H2O2, metal ions, H2S, GSH, and nucleic acids) in biological cells. These MOF-based biological probes offer better sensitivity, good biocompatibility, and targeting features than traditional detection probes, which considerably improves the precision of detection. However, many problems need to be addressed appropriately. For example, the design and development of new MOF-based materials as probes for such biochemical analytes are still required. This is because, the majority of MOFs utilized to build bio-probes in recent years have been based on UiO-66. Furthermore, the sensitivity and selectivity of certain MOF-based bio-probes for the detection of H2O2 are still insufficient for the detection of extracellular hydrogen peroxide concentrations, and the detection limit range is insufficient. The shortcomings/limitations associated with the presently reported MOF-based biofluorescent probes need attention for their widespread application in the future. Perhaps a hybrid of microfluidic chips and electrochemical sensors might be examined, allowing for cell adhesion and growth. The benefits of MOFs may be leveraged by using more than one type of MOF, and the sensor can be provided by employing a multi-MOF method to detect the analytes with appropriate sensitivity outside the cell. Conclusively, the rational design, development and fabrication of biosensors based on MOFs for the effective detection of cellular components is crucial in the biomedical field, despite the fact that there are numerous obstacles and a long way to go.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This research was partially funded by Dongguan Social Development Science and Technology Project (No. 20211800904802), Guangdong Medical University Research Project (1019k2022003), the open research fund of Songshan Lake Materials Laboratory (2022SLABFN12), and Special Funds for Scientific Technological Innovation of Undergraduates in Guangdong Province (pdjh2022a0216, pdjh2022b0225 and pdjh2022b0224; pdjh2023a0228, pdjh2023b0232, pdjh2023b0234, pdjh2023b0237), National Innovation and Entrepreneurship training program for college students (202210571001; 202210571004; 202210571012; S202210571074; S202210571092; S202210571093; S202210571102, 202210571001, 202210571004, S202210571074, S202310571046, S2023010571058, S202310571058, S202310571080, S202310571088 and S202310571089). Guangdong Basic and Applied Basic Research Foundation (2021A1515011616), Featured Innovation Project of Guangdong Province (2022KTSCX045) and Youth Cultivation Fund of Guangdong Medical University (GDMUQ2022017). This research was partially supported by the China Scholarship Council (202108440263).

References

  1. H. Cui, S. Cui, S. Zhang, Q. Tian, Y. Liu, P. Zhang, M. Wang, J. Zhang and X. Li, Analyst, 2021, 146, 5951–5961 RSC .
  2. P. Zhao, S. Chen, J. Zhou, S. Zhang, D. Huo and C. Huo, Anal. Chim. Acta, 2020, 1128, 90–98 CrossRef CAS PubMed .
  3. Y. Li, P. Zhang, Z. Ouyang, M. Zhang, Z. Lin, J. Li, Z. Su and G. Wei, Adv. Funct. Mater., 2016, 26, 2122–2134 CrossRef CAS .
  4. L. García-Carmona, M. Moreno-Guzmán, A. Martín, S. B. Martínez, A. B. Fernández-Martínez, M. C. González, J. Lucio-Cazaña and A. Escarpa, Biosens. Bioelectron., 2017, 96, 146–151 CrossRef PubMed .
  5. J. Huang, H. Li, Y. Zhu, Q. Cheng, X. Yang and C. Li, J. Mater. Chem. A, 2015, 3, 8734–8741 RSC .
  6. J. Bai and X. E. Jiang, Anal. Chem., 2013, 85, 8095–8101 CrossRef CAS PubMed .
  7. Y. Zhang, J. Xiao, Y. Sun, L. Wang, X. Dong, J. Ren, W. He and F. Xiao, Biosens. Bioelectron., 2018, 100, 453–461 CrossRef CAS PubMed .
  8. (a) H. Furukawa, K. E. Cordova, M. O’Keeffe and O. M. Yaghi, Nature, 2013, 341, 1230444 Search PubMed ; (b) Y. N. Zeng, G. H. Xu, X. Y. Kong, G. M. Ye, J. Guo, C. Y. Lu, A. Nezamzadeh-Ejhieh, M. S. Khan, J. Q. Liu and Y. Q. Peng, Int. J. Pharm., 2022, 627, 122228 CrossRef CAS PubMed ; (c) S. Liu, Y. Z. Qiu, Y. F. Liu, W. F. Zhang, Z. Dai, D. Srivastava, A. Kumar, Y. Pan and J. Q. Liu, New J. Chem., 2022, 46, 13818–13837 RSC ; (d) C. Y. Rao, D. H. Liao, Y. Pan, Y. Y. Zhong, W. F. Zhang, Q. Ouyang, A. Nezamzadeh-Ejhieh and J. Q. Liu, Expert Opin. Drug Delivery, 2022, 19(10), 1183–1202 CrossRef CAS PubMed ; (e) X. L. Tan, D. H. Liao, C. Y. Rao, L. Y. Zhou, Z. C. Tan, Y. Pan, A. Singh, A. Kumar, J. Q. Liu and B. H. Li, J. Solid State Chem., 2022, 314, 123352 CrossRef CAS ; (f) Q. J. Ding, Z. J. Xu, L. Y. Zhou, C. Y. Rao, W. M. Li, M. Muddassir, H. Sakiyama, B. L. Q. Ouyang and J. Q. Liu, J. Colloid Interface Sci., 2022, 621, 180–194 CrossRef CAS PubMed .
  9. (a) J. Li, Ryan J. Kuppler and H. Zhou, Chem. Soc. Rev., 2009, 38, 1477–1504 RSC ; (b) M. Y. Zeng, J. Y. Chen, L. Zhang, Y. Cheng, C. Y. Lu, Y. F. Liu, A. Singh, M. Trivedi, A. Kumar and J. Q. Liu, Mater. Today. Commun., 2022, 31, 103514 CrossRef ; (c) M. M. Li, S. H. Yin, M. Z. Lin, X. L. Chen, Y. Pan, Y. Q. Peng, J. B. Sun, A. Kumar and J. Q. Liu, J. Mater. Chem. B, 2022, 10, 5105–5128 RSC ; (d) R. Q. Zheng, J. R. Guo, X. Y. Cai, L. J. Bin, C. Y. Lu, A. Singh, M. Trivedi, A. Kumar and J. Q. Liu, Colloids Surf., B, 2022, 213, 112432 CrossRef CAS PubMed .
  10. J. Lee, J. Kim and T. Hyeon, Adv. Mater., 2006, 18, 2073–2094 CrossRef CAS .
  11. (a) D. Wang and E. Sun, Microporous Mesoporous Mater., 2020, 299, 110131 CrossRef CAS ; (b) Y. F. Wang, C. J. Wang, Q. Z. Feng, J. J. Zhai, S. S. Qi, A. G. Zhong, M. M. Chu and D. Q. Xu, Chem. Commun., 2022, 58, 6653–6656 RSC ; (c) H. Y. Sun, S. X. Chen, A. G. Zhong, R. Sun, J. J. Jin, J. H. Yang, D. Z. Liu, J. F. Niu and S. L. Lu, Molecules, 2023, 28, 3282 CrossRef CAS PubMed .
  12. (a) J. D. Obayemi, S. M. Jusu, A. A. Salifu, S. Ghahremani, M. Tadesse, V. O. Uzonwanne and W. O. Soboyejo, Mater. Sci. Eng. C, 2020, 112, 110794 CrossRef CAS PubMed ; (b) Q. Z. Yang, Y. J. Wen, A. G. Zhong, J. Xu and S. J. Shao, New J. Chem., 2020, 44, 16265–16268 RSC ; (c) S. Y. Liu, W. Q. Liu, C. X. Yuan, A. G. Zhong, D. M. Han, B. Wang, M. N. Shah, M. M. Shi and H. Z. Chen, Dyes Pigm., 2016, 134, 139–147 CrossRef CAS .
  13. L. E. Kreno, K. Leong, O. K. Farha, M. Allendorf, R. P. Van Duyne and J. T. Hupp, Chem. Rev., 2012, 112, 1105–1125 CrossRef CAS PubMed .
  14. Z. Rahmati, R. Khajavian and M. Mirzaei, Inorg. Chem. Front., 2021, 8, 3581–3586 RSC .
  15. A. Zuliani, N. Khiar and C. Carrillo-Carrión, Anal. Bioanal. Chem., 2023, 415, 2005–2023 CrossRef CAS PubMed .
  16. (a) M. Bazargan, F. Ghaemi, A. Amiri and M. Mirzaei, Coord. Chem. Rev., 2021, 445, 214107 CrossRef CAS ; (b) P. Yan, X. Li, D. Y. Ma, L. J. Li, Y. W. Lan, Z. Y. Li, X. T. Lu, M. Q. Yang and F. L. Liang, J. Solid State Chem., 2022, 316, 123566 CrossRef CAS ; (c) L. Qin, Y. Li, D. Y. Ma, F. L. Liang, L. D. Chen, C. Y. Xie, J. Y. Lin, Y. N. Pan, G. Z. Li, F. R. Chen, P. R. Xu, C. L. Hong and J. X. Zhu, J. Solid State Chem., 2022, 312, 123175 CrossRef CAS .
  17. M. Bazargan, M. Mirzaei, A. Amiri and C. Ritchie, Microchim. Acta, 2021, 108, 188 Search PubMed .
  18. J. Wang, C. Wang and W. Lin, ACS Catal., 2012, 2, 2630–2640 CrossRef CAS .
  19. (a) Y. Y. Li, D. Q. C. Li, T. R. Qin, Z. Shi, P. K. Fu, D. Q. Xiong and X. Y. Dong, Appl. Organomet. Chem., 2023, 37, e6920 CrossRef CAS ; (b) X. Y. Dong, Z. Shi, D. Q. C. Li, Y. Y. Li, N. An, Y. J. Shang, H. Sakiyama, M. Muddassir and C. D. Si, J. Solid State Chem., 2023, 318, 123713 CrossRef CAS ; (c) T. R. Qin, Z. Shi, W. J. Zhang, X. Y. Dong, N. An, H. Sakiyama, M. Muddassir, D. Srivastava and A. Kumar, J. Mol. Struct., 2023, 1282, 135220 CrossRef CAS .
  20. (a) P. R. Lakshmi, P. Nanjan, S. Kannan and S. Shanmugaraju, Coord. Chem. Rev., 2021, 435, 213793 CrossRef ; (b) Y. Shu, Q. Ye, T. Dai, Q. Xu and X. Hu, ACS Sens., 2021, 6, 641–658 CrossRef CAS PubMed ; (c) L. E. Kreno, K. Leong, O. K. Farha, M. Allendorf, R. P. Van Duyne and J. T. Hupp, Chem. Rev., 2012, 112, 1105–1125 CrossRef CAS PubMed .
  21. Y. Feng, Y. Wang and Y. Ying, Coord. Chem. Rev., 2021, 446, 214102 CrossRef CAS .
  22. (a) Y. Y. Zhong, Z. X. Peng, Y. Q. Peng, B. Li, Y. Pan, Q. Ouyang, H. Sakiyama, M. Muddassir and J. Q. Liu, J. Mater. Chem. B, 2023 10.1039/D3TB00749A ; (b) W. P. Chen, M. Liu and H. P. Yang, Pharmaceutics, 2023, 15, 1323 CrossRef CAS PubMed ; (c) X. L. Chen, M. M. Li, M. Z. Lin, C. Y. Lu, A. Kumar, Y. Pan, J. Q. Liu and Y. Q. Peng, J. Mater. Chem. B, 2023 10.1039/D3TB00267E ; (d) J. Y. Chen, Z. X. Zhang, J. X. Ma, A. Nezamzadeh-Ejhieh, C. Y. Lu, Y. Pana, J. Q. Liu and Z. Bai, Dalton Trans., 2023, 52, 6226–6238 RSC ; (e) Z. J. Xu, Z. Y. Wu, S. Huang, K. H. Ye, Y. H. Jiang, J. Q. Liu, J. C. Liu, X. W. Lu and B. Li, J. Controlled Release, 2023, 354, 615–625 CrossRef CAS PubMed .
  23. M. Nazari, A. S. Saljooghi, M. Ramezani, M. Alibolandi and M. Mirzaei, J. Mater. Chem. B, 2022, 10, 8824–8851 RSC .
  24. X. Fu, B. Ding and D. D’Alessandro, Coord. Chem. Rev., 2023, 475, 214814 CrossRef CAS .
  25. D. I. Osman, S. M. El-Sheikh, S. M. Sheta, O. I. Ali, A. M. Salem, W. G. Shousha, S. F. El-Khamisy and S. M. Shawky, Biosens. Bioelectron., 2019, 141, 111451 CrossRef CAS PubMed .
  26. T. Liu, R. Hu, Y. Liu, K. Zhang, R. Bai and Y. Yang, Microchim. Acta, 2020, 187, 320 CrossRef CAS PubMed .
  27. N. Wei, M. Y. Zhang, X. N. Zhang, G. M. Li, X. D. Zhang and Z. B. Han, Cryst. Growth Des., 2014, 14, 3002–3009 CrossRef CAS .
  28. (a) S. H. Jung, H. Lee, M. L. Seo and J. H. Jung, Bull. Korean Chem. Soc., 2013, 34, 1583–1585 CrossRef CAS ; (b) F. Ke, A. Pan, J. Q. Liu, X. X. Liu, T. Yuan, C. Y. Zhang, G. N. Fu, C. Y. Peng, J. F. Zhu and X. C. Wan, J. Colloid Interface Sci., 2023, 642, 61–68 CrossRef CAS PubMed .
  29. H. Sohrabi, S. Ghasemzadeh, S. Shakib, M. R. Majidi, A. Razmjou, Y. Yoon and A. Khataee, Ind. Eng. Chem. Res., 2023, 62, 4611–4627 CrossRef CAS .
  30. H. Zheng, C. Liu, X. Zeng, J. Chen, J. Lü, R. Lin, R. Cao, Z. Lin and J. Su, Inorg. Chem., 2018, 57, 9096–9104 CrossRef CAS PubMed .
  31. C. Guo, M. Hu, Z. Li, F. Duan, L. He, Z. Zhang, F. Marchetti and M. Du, Sens. Actuators, B, 2020, 309, 127821 CrossRef CAS .
  32. F. Yu, X. Han and L. Chen, Chem. Commun., 2014, 50, 12234–12249 RSC .
  33. Ü. Anik, S. Timur and Z. Dursun, Microchim. Acta, 2019, 186, 196 CrossRef PubMed .
  34. M. Hu, S. A. A. Razavi, M. Piroozzadeh and A. Morsali, Inorg. Chem. Front., 2020, 7, 1598–1632 RSC .
  35. R. S. Balaban, S. Nemoto and T. Finkel, Cell, 2005, 120, 483–495 CrossRef CAS PubMed .
  36. K. B. Beckman and B. N. Ames, Physiol. Rev., 1998, 78, 547–581 CrossRef CAS PubMed .
  37. T. Finkel, M. Serrano and M. A. Blasco, Nature, 2007, 448, 767–774 CrossRef CAS PubMed .
  38. J. P. Fruehauf and F. L. Meyskens, Clin. Cancer Res., 2007, 13, 789–794 CrossRef CAS PubMed .
  39. N. Houstis, E. D. Rosen and E. S. Lander, Nature, 2006, 440, 944–948 CrossRef CAS PubMed .
  40. D. Jay, H. Hitomi and K. K. Griendling, Free Radical Biol. Med., 2006, 40, 183–192 CrossRef CAS PubMed .
  41. M. P. Mattson, Nature, 2004, 430, 631–639 CrossRef CAS PubMed .
  42. M. T. Lin and M. F. Beal, Nature, 2006, 443, 787–795 CrossRef CAS PubMed .
  43. B. Balasubramanian, W. K. Pogozeldki and T. D. Tullius, Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 9738–9743 CrossRef CAS PubMed .
  44. C. Li, R. Wu, J. Zou, T. Zhang, S. Zhang, Z. Zhang, X. Hu, Y. Yan and X. Ling, Biosens. Bioelectron., 2018, 116, 81–88 CrossRef CAS PubMed .
  45. Y. Sun, M. Luo, X. Meng, J. Xiang, L. Wang, Q. Ren and S. Guo, Anal. Chem., 2017, 89, 3761–3767 CrossRef CAS PubMed .
  46. W. Huang, Y. Xu, Z. Wang, K. Liao, Y. Zhang and Y. Sun, Talanta, 2022, 249, 123612 CrossRef CAS PubMed .
  47. J. Liu, X. Bo, J. Yang, D. Yin and L. Guo, Sens. Actuators, B, 2017, 248, 207–213 CrossRef CAS .
  48. J. Lu, Y. Hu, P. Wang, P. Liu, Z. Chen and D. Sun, Sens. Actuators, B, 2020, 311, 127909 CrossRef CAS .
  49. H. Wang, W. Chen, Q. Chen, N. Liu, H. Cheng and T. Li, Electroanal. Chem., 2021, 897, 115603 CrossRef CAS .
  50. Q. Wang, Y. Yang, F. Gao, J. Ni, Y. Zhang and Z. Lin, ACS Appl. Mater. Interfaces, 2016, 8, 32477–32487 CrossRef CAS PubMed .
  51. L. Chen, T. Wang, Y. Xue, X. Zhou, J. Zhou, X. Cheng, Z. Xie, Q. Kuang and L. Zheng, Adv. Mater. Interfaces, 2018, 5, 1801168 CrossRef .
  52. S. Zhou, L. Jiang, J. Zhang, P. Zhao, M. Yang, D. Huo, X. Luo, C. Shen and C. Hou, Mikrochim. Acta, Suppl., 2021, 188, 160 CrossRef CAS PubMed .
  53. X. Yang, W. Qiu, R. Gao, Y. Wang, Y. Bai, Z. Xu and S. J. Bao, Sens. Actuators, B, 2022, 354, 131201 CrossRef CAS .
  54. J. Deng, K. Wang, M. Wang, P. Yu and L. Mao, J. Am. Chem. Soc., 2017, 139, 5877–5882 CrossRef CAS PubMed .
  55. K. Lu, T. Aung, N. Guo, R. Weichselbaum and W. Lin, Adv. Mater., 2018, 30, 1707634 CrossRef PubMed .
  56. L. He, M. Brasino, C. Mao, S. Cho, W. Park, A. P. Goodwin and J. N. Cha, Small, 2017, 13, 1700504 CrossRef PubMed .
  57. G.-B. Hu, C.-Y. Xiong, W.-B. Liang, X.-S. Zeng, H.-L. Xu, Y. Yang, L.-Y. Yao, R. Yuan and D.-R. Xiao, ACS Appl. Mater. Interfaces, 2018, 10, 15913–15919 CrossRef CAS PubMed .
  58. W.-H. Chen, G.-F. Luo, Y. S. Sohn, R. Nechushtai and I. Willner, Adv. Funct. Mater., 2019, 29, 1805341 CrossRef .
  59. Z. Wang, Y. Fu, Z. Kang, X. Liu, N. Chen, Q. Wang, Y. Tu, L. Wang, S. Song, D. Ling, H. Song, X. Kong and C. Fan, J. Am. Chem. Soc., 2017, 139, 15784–15791 CrossRef CAS PubMed .
  60. M. Sk, S. Banesh, V. Trivedi and S. Biswas, Inorg. Chem., 2018, 57, 14574–14581 CrossRef CAS PubMed .
  61. C. Hao, X. Wu, M. Sun, H. Zhang, A. Yuan, L. Xu, C. Xu and H. Kuang, J. Am. Chem. Soc., 2019, 49, 141 Search PubMed .
  62. Y. Liu, H. Wei, X. Jiang, H. Guo and X. Liu, Electroanal. Chem., 2018, 820, 51–59 CrossRef CAS .
  63. S. Dey, S. Maity, A. Dasmahapatra, D. Chattopadhyay and C. Sinha, ChemistrySelect, 2019, 4, 4472–4477 CrossRef CAS .
  64. T. Fan, T. Xia, Q. Zhang, Y. Cui, Y. Yang and G. Qian, Microporous Mesoporous Mater., 2018, 266, 1–6 CrossRef CAS .
  65. Y. Li, X. Hu, X. Zhang, H. Cao and Y. Huang, Anal. Chim. Acta, 2018, 1024, 145–152 CrossRef CAS PubMed .
  66. X. Shi, H. M. Meng, X. Geng, L. Qu and Z. Li, ACS Sens., 2020, 5, 3150–3157 CrossRef CAS PubMed .
  67. O. Troeppner, R. Lippert, T. E. Shubina, A. Zahl, N. Jux and I. Ivanovi’c-Burmazovi’c, Angew. Chem., Int. Ed., 2014, 53, 11452–11457 CrossRef CAS PubMed .
  68. P. Ravichandiran, A. Boguszewska-Czubara, M. Masłyk, A. P. Bella, S. A. Subramaniyan, P. M. Johnson, K. S. Shim, H. G. Kim and D. J. Yoo, ACS Sustainable Chem. Eng., 2019, 20, 17210–17219 CrossRef .
  69. L. Notini, D. E. Latta, A. Neumann, C. I. Pearce, M. Sassi, A. T. N’Diaye, K. M. Rosso and M. M. Scherer, Environ. Sci. Technol., 2018, 52, 2751–2759 CrossRef CAS PubMed .
  70. Y. Lu, B. Yan and J. L. Liu, Chem. Commun., 2014, 50, 9969–9972 RSC .
  71. Y. Kumar, R. Kaushik, S. Rani, S. Rafat, J. Shabir, K. Dev and L. S. Kumar, Mater. Today Commun., 2021, 28, 102563 CrossRef CAS .
  72. S. M. Hossain, V. Prakash, P. Mamidi, S. Chattopadhyay and A. K. Singh, RSC Adv., 2020, 10, 3646–3658 RSC .
  73. Y. Zhang, Y. Li and L. Zhang, Spectrochim. Acta, Part A, 2021, 259, 119892 CrossRef CAS PubMed .
  74. C. Szabo, C. Coletta, C. Chao, K. Modis, B. Szczesny, A. Pa-papetropoulos and M. R. Hellmich, Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 12474–12479 CrossRef CAS PubMed .
  75. F. Yu, X. Han and L. Chen, Chem. Commun., 2014, 50, 12234–12249 RSC .
  76. J. Liu, K. K. Yee, K. W. Lo, K. Y. Zhang, W. P. To, C. M. Che and Z. Xu, J. Am. Chem. Soc., 2014, 136, 2818–2824 CrossRef CAS PubMed .
  77. Y. Ma, S. Hao, X. Kuang, X. Li and T. Bo, Anal. Chem., 2014, 86, 11459–11463 CrossRef CAS PubMed .
  78. J. Wang, R. C. Zhang, Y. L. Cao, Y. A. Li, Y. R. Wang and Q. L. Wang, New J. Chem., 2018, 42, 3551–3559 RSC .
  79. X. F. Yang, H. B. Zhu and M. Liu, Inorg. Chim. Acta, 2017, 466, 410–416 CrossRef CAS .
  80. S. S. Nagarkar, T. Saha, A. V. Desai, P. Talukdar and S. K. Ghosh, Sci. Rep., 2014, 4, 7053 CrossRef CAS PubMed .
  81. X. Xin, J. Wang and C. Gong, Sci. Rep., 2016, 6, 21951 CrossRef CAS PubMed .
  82. A. Das, S. Banesh, V. Trivedi and S. Biswas, Dalton Trans., 2018, 47, 2690–2700 RSC .
  83. A. Yuan, C. Hao, X. Wu, M. Sun, A. Qu, L. Xu, H. Kuang and C. Xu, Adv. Mater., 2020, 32, 1906580.1–1906580.7 Search PubMed .
  84. H. J. Forman, H. Zhang and A. Rinna, Mol. Aspects Med., 2009, 30, 1–12 CrossRef CAS PubMed .
  85. B. Ketterer, B. Coles and D. J. Meyer, Environ. Health Perspect., 1983, 49, 59–69 CrossRef CAS PubMed .
  86. E. Hatem, N. E. Banna and M. E. Huang, Antioxid. Redox Signaling, 2017, 27, 1217–1234 CrossRef CAS PubMed .
  87. S. Awasthi, S. S. Singhal, R. Sharma, P. Zimniak and Y. C. Awasthi, Int. J. Cancer, 2003, 106, 635–646 CrossRef CAS PubMed .
  88. K. Huang, L. Huang and R. B. Van Breemen, Anal. Chem., 2015, 87, 3646–3654 CrossRef CAS PubMed .
  89. W. Zhu, G. Jiang, L. Xu, B. Li, Q. Cai, H. Jiang and X. Zhou, Anal. Chim. Acta, 2015, 886, 37–47 CrossRef CAS PubMed .
  90. P. Ni, Y. Sun, H. Dai, J. Hu, S. Jiang, Y. Wang and Z. Li, Biosens. Bioelectron., 2015, 63, 47–52 CrossRef CAS PubMed .
  91. J. Tang, B. Kong, Y. Wang, M. Xu, Y. Wang, H. Wu and G. Zheng, Nano Lett., 2013, 13, 5350–5354 CrossRef CAS PubMed .
  92. A. Saha and N. R. Jana, Anal. Chem., 2013, 85, 9221–9228 CrossRef CAS PubMed .
  93. J. H. Bong, H. W. Song, T. H. Kim, M. J. Kang, J. Jose and J. C. Pyun, Biosens. Bioelectron., 2018, 102, 600–609 CrossRef CAS PubMed .
  94. Y. Wang, K. Jiang, J. Zhu, L. Zhang and H. Lin, Chem. Commun., 2015, 51, 12748–12751 RSC .
  95. Y. A. Li, C. W. Zhao and N. X. Zhu, Chem. Commun., 2015, 51, 17672–17675 RSC .
  96. S. Zhu, S. Wang, M. Xia, B. Wang, Y. Huang, D. Zhang, X. Zhang and G. Wang, ACS Appl. Mater. Interfaces, 2019, 11, 31693–31699 CrossRef CAS PubMed .
  97. P. Yang, Y. Zheng, Y. Wang, J. Yue, G. Gao, Y. Ma and B. Tang, Sens. Actuators, B, 2021, 348, 130680 CrossRef CAS .
  98. H. Peng, A. M. Newbigging, M. S. Reid, J. S. Uppal and X. C. Le, Anal. Chem., 2020, 92, 292–308 CrossRef CAS PubMed .
  99. S. W. Kim, Z. Li, P. S. Moore, A. P. Monaghan and Y. Chang, Nucleic Acids Res., 2010, 38, 98 CrossRef PubMed .
  100. C. Chen, D. A. Ridzon and A. J. Broomer, Nucleic Acids Res., 2005, 33, 179 CrossRef PubMed .
  101. J. Q. Yin, R. C. Zhao and K. V. Morris, Trends Biotechnol., 2008, 26, 70–76 CrossRef CAS PubMed .
  102. Y. Wu, J. Han, P. Xue, R. Xu and Y. Kang, Nanoscale, 2015, 7, 1753–1759 RSC .
  103. X. Wei, L. Zheng, F. Luo, Z. Lin, L. Guo, B. Qiu and G. Chen, J. Mater. Chem. B, 2013, 1, 1812–1817 RSC .
  104. M. Hu, L. Zhu, Z. Li, C. Guo, M. Wang, C. Wang and M. Du, Appl. Surf. Sci., 2021, 542, 148586 CrossRef CAS .
  105. C. Yang, K. Wang, Z. Li, L. Mo and W. Lin, Sens. Actuators, B, 2022, 359, 131593 CrossRef CAS .
  106. J. Xu, J. Guo, N. Golob-Schwarzl, J. Haybaeck, X. Qiu and N. Hildebrandt, ACS Sens., 2020, 5, 1768–1776 CrossRef CAS PubMed .

Footnote

These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry 2023
Click here to see how this site uses Cookies. View our privacy policy here.